Suppr超能文献

山羊心脏中抑制蛋白IF(1)对F(0)F(1)ATP合酶调节的体外和体内研究

In vitro and in vivo studies of F(0)F(1)ATP synthase regulation by inhibitor protein IF(1) in goat heart.

作者信息

Di Pancrazio Francesca, Mavelli Irene, Isola Miriam, Losano Gianni, Pagliaro Pasquale, Harris David A, Lippe Giovanna

机构信息

Department of Biomedical Sciences and Technologies and M.A.T.I. Center of Excellence, University of Udine, p.le Kolbe 4, 33100 Udine, Italy.

出版信息

Biochim Biophys Acta. 2004 Nov 4;1659(1):52-62. doi: 10.1016/j.bbabio.2004.07.009.

Abstract

A method has been developed to allow the level of F(0)F(1)ATP synthase capacity and the quantity of IF(1) bound to this enzyme be measured in single biopsy samples of goat heart. ATP synthase capacity was determined from the maximal mitochondrial ATP hydrolysis rate and IF(1) content was determined by detergent extraction followed by blue native gel electrophoresis, two-dimensional SDS-PAGE and immunoblotting with anti-IF(1) antibodies. Anaesthetized open-chest goats were subjected to ischemic preconditioning and/or sudden increases of coronary blood flow (CBF) (reactive hyperemia). When hyperemia was induced before ischemic preconditioning, a steep increase in synthase capacity, followed by a deep decrease, was observed. In contrast, hyperemia did not affect synthase capacity when applied after ischemic preconditioning. Similar effects could be produced in vitro by treatment of heart biopsy samples with anoxia (down-regulation of the ATP synthase) or high-salt or high-pH buffers (up-regulation). We show that both in vitro and in vivo the same close inverse correlation exists between enzyme activity and IF(1) content, demonstrating that under all conditions tested the only significant modulator of the enzyme activity was IF(1). In addition, both in vivo and in vitro, 1.3-1.4 mol of IF(1) was predicted to fully inactivate 1 mol of synthase, thus excluding the existence of significant numbers of non-inhibitory binding sites for IF(1) in the F(0) sector.

摘要

已开发出一种方法,可在山羊心脏的单个活检样本中测量F(0)F(1)ATP合酶的活性水平以及与该酶结合的IF(1)的量。根据线粒体最大ATP水解速率确定ATP合酶活性,通过去污剂提取、随后的蓝色非变性凝胶电泳、二维SDS-PAGE以及用抗IF(1)抗体进行免疫印迹来确定IF(1)含量。对麻醉开胸的山羊进行缺血预处理和/或冠状动脉血流量(CBF)突然增加(反应性充血)。当在缺血预处理前诱导充血时,观察到合酶活性急剧增加,随后大幅下降。相反,在缺血预处理后进行充血时,充血并不影响合酶活性。通过用缺氧(ATP合酶下调)或高盐或高pH缓冲液(上调)处理心脏活检样本,在体外也可产生类似效果。我们表明,在体外和体内,酶活性与IF(1)含量之间都存在相同的紧密负相关,这表明在所有测试条件下,酶活性的唯一重要调节因子是IF(1)。此外,在体内和体外,预计1.3 - 1.4摩尔的IF(1)可使1摩尔的合酶完全失活,从而排除了F(0)区段中存在大量IF(1)非抑制性结合位点的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验